Evidence map›Paper›PMID 41305001›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

Jing Hong, Fangyu Zhang, Ruizhen Zhang, Hongyang Fu, Dongang Shen, Xinyue Wang, Yuting Yang, Jiamei Wu, Lin Meng, Hongyang Lü and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jing HongSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Fangyu ZhangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Ruizhen ZhangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Hongyang FuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Dongang ShenSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xinyue WangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yuting YangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Jiamei WuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lin MengSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Hongyang LüSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xiwei JiangSchool of Medical Devices, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yunli ZhaoSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0002-4775-2811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardioprotectioncardiotoxicityCPT1BDHDKdoxorubicin exposureFAOPPARG

Identifiers

PMID41305001
PMCPMC12655265

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.